Immune Therapy Works As Well In Senior Cancer Patients As In Younger Adults

Follow Drugslib on

Medically reviewed by Drugs.com.

By Dennis Thompson HealthDay Reporter

TUESDAY, April 22, 2025 — It’s well-known that a person’s immune system wears down over time, becoming less effective as folks progress through middle age and become seniors.

But that doesn’t appear to hinder the effectiveness of immunotherapy for cancer in seniors, a new study says.

Seniors with cancer respond just as well as younger patients to immune checkpoint inhibitors — drugs that take the brakes off the immune system so it can target and kill cancer cells more effectively, researchers reported April 21 in the journal Nature Communications.

“Older patients do just as well, sometimes better than younger patients with immunotherapy treatments,” said senior researcher Dr. Daniel Zabransky, an assistant professor of oncology at Johns Hopkins University School of Medicine.

“We found clues about important pathways mediating the immune system response to immunotherapies in younger versus older patients that may help us improve the next generation of therapies or allow us to use current therapies in all patients more effectively,” Zabransky added in a news release.

Most new cancer diagnoses occur in people 65 and older, and overall these folks have worse cancer treatment outcomes, researchers said in background notes.

In part, this is because their aging immune systems make it harder for their bodies to fight cancer cells, researchers said.

But it’s unclear whether immunotherapy can help people overcome these effects of aging.

For this study, researchers examined immune response in the blood of about 100 cancer patients treated with immune checkpoint inhibitors, of whom about half were 65 or older.

Both groups benefitted from immunotherapy equally, researchers found.

There were, however, important differences in their immune responses, results show.

For example, hunter/killer T cells in seniors appeared less ready to respond to threats like cancer without a boost from an immune checkpoint inhibitor, researchers found.

These differences might make immunotherapy drugs even more beneficial for older patients, they said.

Researchers next plan to look at differences in the immune cells found inside tumors, and compare them across age groups to see how they react to immunotherapy.

By understanding age-related differences, researchers might be able to hone new cancer therapies so they can be better targeted to patients based on age.

“Right now, we give immune checkpoint inhibitors to patients in the same way without major consideration about how their age may influence how the immune system may recognize cancer cells,” Zabransky said. “By better understanding age-related changes that we all experience over our lifespan, we hope to identify new strategies and personalize our therapies even further based on those important patient-level factors.”

Sources

  • Johns Hopkins Medicine, news release, April 21, 2025

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2025-04-23 00:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords